Bullish option flow detected in Bristol Myers Squibb with 17,929 calls trading, 1.8x expected, and implied vol increasing over 1 point to 28.63%. Sep-24 46 calls and Jan-25 35 puts are the most active options, with total volume in those strikes near 12,800 contracts. The Put/Call Ratio is 0.42. Earnings are expected on July 26th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers announces FDA accelerated approval of Krazati for CRC
- FDA approves Mirati’s Krazati sNDA for colorectal cancer
- Bristol Myers: EMA validates extension application for subcutaneous nivolumab
- Bristol Myers says FDA grants accelerated approval of Augtyro
- I-Mab announces clinical trial collaboration with Bristol Myers